Annual Meeting Agenda
This year's general session focuses on the latest science, surgical innovations, and practice-changing information for breast surgeons. We've planned a variety of learning opportunities and networking events, and more will be added in the weeks ahead! Arrive early to participate in our Pre-Meeting Program — courses begin Wednesday, April 30.
Wednesday, April 30
Pre-Meeting Courses
Wed, April 30, 8:00 AM – 5:00 PM
*Limited Enrollment*
Learn MoreEvening Industry Symposia
Wed, April 30, 7:00 PM – 8:30 PM
Non-CME
Thursday, May 1
Pre-Meeting Courses
Thu, May 1, 7:00 AM – 1:00 PM
*Limited Enrollment*
Learn MoreWelcome
Thu, May 1, 1:00 PM – 1:15 PM
Presenters: Judy C. Boughey, MD, FACS; Kari M. Rosenkranz, MD, FACS
Coding, Reimbursement, and Quality Symposium
Thu, May 1, 1:15 PM – 2:30 PM
Moderators: Richard E. Fine, MD, FACS; Walton A. Taylor, MD, FACS
-
Coding and Reimbursement
Linda K. Han, MD, FACS, FSSO -
Coding and Reimbursement Panel Q&A
Richard E. Fine, MD, FACS; Linda K. Han, MD, FACS, FSSO; Walton A. Taylor, MD, FACS -
EUSOMA Quality Indicators
Isabel T. Rubio, MD, PhD -
NAPBC Quality Measures and Standards
Paul L. Baron, MD, FACS -
Q&A
Scientific Oral Presentations 1
Thu, May 1, 2:30 PM – 3:15 PM
Moderators: Sarah L. Blair, MD, FACS; Megan Miller, MD, FACS
-
Welcome and Introduction
Sarah L. Blair, MD, FACS; Megan Miller, MD, FACS -
Validation of the Performance of the Novel Prognostic Staging System for Overall Survival in De Novo Metastatic Breast Cancer and Demonstration of Performance for Cancer Specific Outcomes
Christopher Vetter, MD -
Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial
Rita A. Mukhtar, MD, FACS -
From Podium to PubMed: Successful Manuscript Publication of Breast Surgical Oncology Presentations at National Meetings from 2017–2022
Margaret R. Summerside -
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial
Julie Van Hassel, MD -
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
Dennis R. Holmes, MD, FACS
Multidisciplinary Communication in the Era of De-escalation
Thu, May 1, 3:15 PM – 4:15 PM
Moderators: Giacomo Montagna, MD, MPH, FACS; Alyssa D. Throckmorton, MD, FACS
-
Welcome and Introduction
Giacomo Montagna, MD, MPH, FACS; Alyssa D. Throckmorton, MD, FACS -
What to Omit and When: Management of ER+ HER- Axillary Disease
Rachel L. McCaffrey, MD, FACS -
CDK4/6 Inhibition: What Do Surgeons Need to Know?
Austin D. Williams, MD, MSEd, FACS -
Omission of Radiation With Nodal pCR to Neoadjuvant Chemotherapy
Jennifer K. Plichta, MD, MS, FACS -
Omission of Surgery After Neoadjuvant Chemotherapy
Isabel T. Rubio, MD, PhD -
Q&A
Outside the Clinical Trials
Thu, May 1, 4:15 PM – 5:00 PM
Moderators: Richard J. Barth, Jr., MD, FACS; Stephanie Serres, MD, PhD
-
Welcome and Introduction
Richard J. Barth, Jr., MD, FACS; Stephanie Serres, MD, PhD -
Evidence for Complementary and Alternative Medicine (CAM)
Theresa L. Schwartz, MD, MS, FACS -
Ethics of Complementary and Alternative Medicine (CAM)
Jennifer H. Fieber, MD, FACS -
Spirituality and Religion
Katherina Zabicki Calvillo, MD, FACS -
Q&A
Debate: DCIS Should Be Managed With Observation Alone
Thu, May 1, 5:00 PM – 5:30 PM
Non-CME
Moderators: Kari J. Kansal, MD, FACS; Alastair M. Thompson, MD, BSc(Hons), MB ChB, MD, FRCSEd FACS
-
Welcome and Introduction
Kari J. Kansal, MD, FACS; Alastair M. Thompson, MD, BSc(Hons), MB ChB, MD, FRCSEd FACS -
Pro: Observation for DCIS
E. Shelley Hwang, MD, MPH, FACS -
Con: Surgical Resection for DCIS
Kimberly J. Van Zee, MS, MD, FACS -
Take Home Message for DCIS Management in 2025
Anna Weiss, MD, FACS
Evening Industry Symposium
Thu, May 1, 5:30 PM – 7:00 PM
Non-CME
Friday, May 2
Breakfast Industry Symposia
Fri, May 2, 6:15 AM – 7:45 AM
Non-CME
Welcome
Fri, May 2, 8:00 AM – 8:15 AM
Presenters: Judy C. Boughey, MD, FACS; Kari M. Rosenkranz, MD, FACS
Debate: Contralateral Prophylactic Mastectomy
Fri, May 2, 8:15 AM – 9:00 AM
Moderators: Rachel A. Greenup, MD, MPH, FACS; Paige Teller, MD, FACS
-
Welcome and Introduction
Rachel A. Greenup, MD, MPH, FACS; Paige Teller, MD, FACS -
Pro Contralateral Prophylactic Mastectomy
Lee G. Wilke, MD, FACS -
Against Contralateral Prophylactic Mastectomy
Funda Meric-Bernstam, MD, FACS -
Summary and Best Practice for Contralateral Prophylactic Mastectomy in 2025
Laura S. Dominici, MD, FACS -
International Perspective on Contralateral Prophylactic Mastectomy
Marie Jeanne Vrancken Peeters, MD, PhD
Invasive Lobular Breast Cancer: It Isn’t Just Ductal
Fri, May 2, 9:00 AM – 10:00 AM
Moderators: Anna C. Beck, MD; Lillian M. Erdahl, MD, FACS
-
Welcome and Introduction
Anna C. Beck, MD; Lillian M. Erdahl, MD, FACS -
Welcome and Introduction
Evelyn F. Carroll, MD -
Genetics and Invasive Lobular Carcinoma
Lauren A. Gamble, MD -
Surgical Management of the Breast in Invasive Lobular Carcinoma
Rita A. Mukhtar, MD, FACS -
Surgical Management of the Axilla in Invasive Lobular Carcinoma
Michael R. Cassidy, MD, FACS -
Neoadjuvant Therapy for Invasive Lobular Carcinoma
Meghan R. Flanagan, MD, MPH, FACS -
Q&A
“How I Do It” Videos
Fri, May 2, 10:00 AM – 10:30 AM
Moderators: Katrina B. Mitchell, MD, IBCLC, FACS; Courtney A. Vito, MD, FACS
Break in the Exhibit Hall
Fri, May 2, 10:30 AM – 11:00 AM
Non-CME
Debate: Is Breast Conservation Safer Than Mastectomy?
Fri, May 2, 11:00 AM – 11:45 AM
Moderators: Christine Laronga, MD, FACS; Jennifer E. Tonneson, MD, FACS
-
Welcome and Introduction
Christine Laronga, MD, FACS; Jennifer E. Tonneson, MD, FACS -
Pro Mastectomy
Kandace P. McGuire, MD, FACS -
Pro Breast Conservation Therapy
Mahmoud El-Tamer, MD, FACS -
Summary and Best Practice of Breast Conservation vs Mastectomy in 2025
Stephanie Downs-Canner, MD, FACS -
Ethics of Shared Decision Making in Era as Data Evolve
Puneet Singh, MD, FACS
Keynote Address
Fri, May 2, 11:45 AM – 12:45 PM
-
Keynote Address Introduction
Judy C. Boughey, MD, FACS -
Keynote Address: “Re-imagining Stage 0 and 1 Breast Cancer”
Bruce Mann, MBBS, PhD, FRACS
Lunch in the Exhibit Hall
Fri, May 2, 12:45 PM – 1:45 PM
Non-CME
Maximizing Your Breast Surgery Practice
Fri, May 2, 1:45 PM – 2:30 PM
Moderators: Lana Shikhman, MD, FACS; Jennifer Tseng, MD, FACS
-
Welcome and Introduction
Lana Shikhman, MD, FACS; Jennifer Tseng, MD, FACS -
Optimizing APPs in a Successful Breast Practice
Kimberly A. Hoskins, NP; Melissa Pilewskie, MD, FACS -
Quality of Care: Institutional and Individual Surgeon Assessments
Richard L. White, Jr., MD, FACS -
Industry Relationships: Navigating the Value and Challenges
Sarah A. McLaughlin, MD, FACS -
Q&A
Scientific Oral Presentations 2
Fri, May 2, 2:30 PM – 3:45 PM
Moderators: Catherine C. Parker, MD, FACS; Mediget Teshome, MD, MPH, FACS
-
Welcome and Introduction
Catherine C. Parker, MD, FACS; Mediget Teshome, MD, MPH, FACS -
Margin Width and Local Recurrence in the NRG Oncology/NSABP B-35 DCIS Lumpectomy Trial
Irene L. Wapnir, MD -
90 days of Pre-Operative Endocrine Therapy Informs Patient and Physician Preference for Radiation Therapy: Primary results from the Pre-Operative Window of Endocrine Therapy to Inform Radiation Therapy Decisions (POWER) Trial
Shayna L. Showalter, MD, FACS -
Ultrasound Guided Intratumoral Delivery of Immunotherapy in Breast Cancer
Camille Baumrucker, MD -
Evaluating the Effect of a Multidisciplinary Breast Cancer Clinic on Time to Treatment at an Urban, Safety Net Hospital
Anna Kobzeva-Herzog, MD -
Impact of Quality Improvement Interventions on Biopsy to Treatment Time in Breast Cancer: Results from the PROMPT Quality Collaborative of the National Accreditation Program for Breast Centers
Danielle Thompson, MD -
Surgeon Recommendation Drives Receipt of Sentinel Lymph Node Biopsy in Women 70 and Over
Heather Neuman, MD -
A Prospective, Randomized Controlled Study to Evaluate Efficacy of Argon Beam Coagulation Versus Conventional Electrosurgical Coagulation for Cutting and Coagulation During Mastectomy with Reconstruction
Stacey Cartner, MD
Break in Exhibit Hall
Fri, May 2, 3:45 PM – 4:15 PM
Non-CME
Cultural Competencies in Breast Surgery
Fri, May 2, 4:15 PM – 5:00 PM
Moderators: Alaina D. Geary, MD, MHPE; Lauren M. Postlewait, MD, FACS
-
Welcome and Introduction
Alaina D. Geary, MD, MHPE; Lauren M. Postlewait, MD, FACS -
Cultural Awareness in the Care of Breast Cancer Patients
Olga Kantor, MD, FACS -
Screening for Breast Cancer in the Transgender Population
Evelyn F. Carroll, MD -
Management of High-Risk and Breast Cancer in the Transgender Population
Chandler S. Cortina, MD, MS, FSSO, FACS -
Racial Disparities in Access and Outcomes for Women with Breast Cancer
Shon M. Black, MD, FACS, FSSO -
Financial Toxicity
Mary L. Gemignani, MD, MPH, FACS -
Q&A
Quickshots Presentations
Fri, May 2, 5:00 PM – 6:00 PM
Moderators: Carla S. Fisher, MD, MBA, FACS; Marissa M. Howard-McNatt, MD, FACS
-
Welcome and Introduction
Carla S. Fisher, MD, MBA, FACS; Marissa M. Howard-McNatt, MD, FACS -
Neighborhood-Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation
Priyanka Parmar, MD -
Second Opinions, Same Standards: Time to Treatment for Breast Cancers Diagnosed Externally
Pooja Varman, MD, MS -
Association of Surgeon Volume with Adherence to American Society of Breast Surgeons Surgical Quality Measures
Kelley Chan, MD, MS -
Evaluating the Impact of a Surgeon-Led Ductal Carcinoma in Situ Program on Endocrine Therapy Uptake
Monika K. Masanam, MD -
Impact of Pathologic Complete Response on Local-Regional Recurrence in Patients Undergoing Neoadjuvant Chemotherapy and Breast Conserving Surgery
Victoria Huynh, MD -
Low Complication Rates After Invasive Procedures on the Lactating Breast in Patients Treated for Breast Cancer During Pregnancy
Jennifer H. Chen, MD -
Pitfalls of Nipple-Sparing Mastectomy: Recurrences are in the Nipple and Axilla
Swetha Duraiswamy, MD -
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors: A Feasibility Study
Ellery H. Reason
Evening Industry Symposia
Fri, May 2, 7:15 PM – 9:00 PM
Non-CME
Saturday, May 3
Breakfast Industry Symposia
Sat, May 3, 6:30 AM – 7:45 AM
Non-CME
Hoag Hospital Surgical Innovation Forum: Innovative Surgical Techniques
Sat, May 3, 8:00 AM – 9:00 AM
Moderators: Julie A. Billar, MD; Abhishek Chatterjee, MD, MBA, FACS
-
Welcome and Introduction
Julie A. Billar, MD; Abhishek Chatterjee, MD, MBA, FACS -
Robotic Mastectomy
Mara A. Piltin, DO, FACS -
Lymphovenous Bypass and Lymph Node Transfer
Zahraa Al-Hilli, MD, MBA, FACS, FRCSI -
Extreme Oncoplasty
Kristalyn K. Gallagher, DO, FACOS, FACS -
Minimally Invasive Vacuum Assisted Excision for Small Cancers
Stuart A. McIntosh, MBChB, PhD -
Advances in Breast Reconstruction
Scott T. Hollenbeck, MD, FACS -
Q&A
Scientific Oral Presentations 3
Sat, May 3, 9:00 AM – 10:00 AM
Moderators: Leslie L. Montgomery, MD, FACS, FSSO; Candice Sauder, MD, MEd, FACS
-
Welcome and Introduction
Leslie L. Montgomery, MD, FACS, FSSO; Candice Sauder, MD, MEd, FACS -
Reducing Seroma Formation After Mastectomy by Performing Flap Fixation Techniques: A Multi-Center, Double-Blind Randomized Controlled Trial Including Technical Aspects and Economic Evaluation
Merel A. Spiekerman van Weezelenburg, MD -
Association of Margin Width and Local Recurrence Following Mastectomy for DCIS
Amanda L. Nash, MD -
Pre-Treatment Tumor Collagen is Associated with Triple-Negative Breast Cancer Pathological Response to Chemo-Immunotherapy
Mackenzie Jones, MD -
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial
Mandeep Kaur -
Survival Differences Persist Despite Less Intensive Treatment for Women Diagnosed with Early-Stage Breast Cancer via Active Screening
Melissa Edwards, BSc, MBChB, PGDip, PhD, FRACS -
A Prospective, Multi-Center, Randomized, Double-Arm Clinical Trial To Assess the Positive Margin Rate of Breast-Conserving Surgery With or Without the Aid of an Intraoperative Optical Coherence Tomography System
Alastair M. Thompson, MD, BSc(Hons), MB ChB, MD, FRCSEd FACS
Break in the Exhibit Hall
Sat, May 3, 10:00 AM – 10:30 AM
Non-CME
2024 Best Papers
Sat, May 3, 10:30 AM – 11:30 AM
-
Welcome and Introduction
Kari M. Rosenkranz, MD, FACS -
2024 Best Papers
Helen A. Pass, MD, FACS
Presidential Address
Sat, May 3, 11:30 AM – 12:30 PM
-
Presidential Address Introduction
Michael P. Berry, MD, FACS -
Presidential Address
Judy C. Boughey, MD, FACS
Lunch in the Exhibit Hall
Sat, May 3, 12:30 PM – 1:30 PM
Non-CME
Multidisciplinary Care and Tumor Biology
Sat, May 3, 1:30 PM – 3:00 PM
Moderators: Elizabeth A. Mittendorf, MD, PhD, FACS; Jamie L. Wagner, DO, MBA, FACOS, FACS
-
Welcome and Introduction
Elizabeth A. Mittendorf, MD, PhD, FACS; Jamie L. Wagner, DO, MBA, FACOS, FACS -
Debate: All Patients Should Be Treated With Neoadjuvant Systemic Therapy Followed by Surgery
Laura J. Esserman, MD, MBA, FACS -
Standard of Care Remains Upfront Surgery Followed by Systemic Therapy
Mehra Golshan, MD, MBA FACS -
Optimal Management Strategy in 2025
Mediget Teshome, MD, MPH, FACS -
Indications and Benefits of Immunotherapy: Triple-negative Breast Cancer and Luminal Breast Cancer
Julia Tchou, MD, PhD, FACS -
Perioperative Management of Patients on Immunotherapy: Important Information for Surgeons and Anethesia
Tina J. Hieken, MD, FACS -
Q&A
-
Debate: Axillary Lymph Node Dissection Is Recommended After Neoadjuvant Chemotherapy for Residual Node Positive Disease
Marie Jeanne Vrancken Peeters, MD, PhD -
Radiation Therapy Can Replace Axillary Lymph Node Dissection for Residual Node Positive Disease After Neoadjuvant Chemotherapy
Walter P. Weber, MD -
Management of Residual Node Positive Disease in 2025 While We Await More Data
Kelly K. Hunt, MD, FACS -
Q&A
Break in the Exhibit Hall
Sat, May 3, 3:00 PM – 3:30 PM
Non-CME
Your ASBrS: We Are Your Society
Sat, May 3, 3:30 PM – 4:30 PM
Non-CME
-
Annual Business Meeting
-
Salary Survey
Eric R. Manahan, MD, MBA, FACS -
2024-2025 ASBrS Year in Review
Judy C. Boughey, MD, FACS -
Changes in Breast Surgical Oncology Fellowship Training Experience Over the Years
Andrea Madrigrano, MD -
Analysis of the 2024 Breast Surgical Oncology Fellowship Match: Survey of Applicants and Program Directors Preferences Regarding In-Person vs Virtual Interviews
Jennifer K. Plichta, MD, MS, FACS -
Oral Presentation and Poster Presentation Awards
Sarah L. Blair, MD, FACS -
Recognition of Newly Certified Individuals
Michele M. Carpenter, MD, FACS; Nicole Demos, PA-C -
Meet the ASBrS Board and Staff and Awards Presentation
Management of Unique Populations
Sat, May 3, 4:30 PM – 5:30 PM
Moderators: Lesly A. Dossett, MD, MPH, FACS; Susan B. Kesmodel, MD, FACS
-
Welcome and Introduction
Lesly A. Dossett, MD, MPH, FACS; Susan B. Kesmodel, MD, FACS -
Elderly: When to Stop Screening, Omission of Surgery (endocrine therapy alone vs cyroblation)
Ingrid M. Lizarraga, MBBS, FACS -
Pregnant Patient and Pregnancy After Breast Cancer
Jacqueline Jeruss, MD, PhD, FACS -
Recurrent Breast Cancer
Mary M. Mrdutt, MD, MS, FACS -
Adolescent and Young Adults: Management and Survivorship
Candice Sauder, MD, MEd, FACS -
Male Breast Cancer
Lucy M. De La Cruz, MD, FACS -
Q&A
Communicating With Our Patients
Sat, May 3, 5:30 PM – 6:15 PM
Moderators: Vivian J. Bea, MD, MBS, FACS; Jillian K. Smith, MD, MPH, FACS
-
Welcome and Introduction
Vivian J. Bea, MD, MBS, FACS; Jillian K. Smith, MD, MPH, FACS -
Patient Perspective
Amanda Echalaz, BMus Hons -
Empathy is Not as Easy as It Sounds
Rakhshanda Layeequr Rahman, MD, FACS -
Shared Decision-Making Tools
Julie A. Margenthaler, MD, FACS -
Integrating Patient-reported Outcomes Into Patient Counseling
Sarah Tevis, MD, FACS -
Q&A
ASBrS 2025 Gala
Sat, May 3, 7:15 PM – 9:30 PM
Non-CME
Sunday, May 4
Axillary Management in 2025 and Beyond
Sun, May 4, 8:00 AM – 9:00 AM
Moderators: Steven Cai, MD, FACS; Jennifer K. Plichta, MD, MS, FACS
-
Welcome and Introduction
Steven Cai, MD, FACS; Jennifer K. Plichta, MD, MS, FACS -
Axillary Surgery in the Clinically Negative Axilla in Patients Undergoing Upfront Surgery?
Oluwadamilola “Lola” M. Fayanju, MD, MA, MPHS, FACS -
Axillary Surgery for Patients With Ultrasound Biopsy Positive Node(s) [cN1 disease] Undergoing Upfront Surgery
Akiko Chiba, MD, FACS -
Axillary Management of 1-2 Positive Nodes After Treatment With Neoadjuvant Endocrine Therapy
Arielle P. Stafford, MD, FACS -
Is Axillary Lymph Node Dissection Required in cN2/N3 Disease with Imaging Response After Neoadjuvant Systemic Therapy?
Roshni Rao, MD, FACS -
Omission of Radiation in cN+ Disease with Response to Neoadjuvant Systemic Therapy
Bruce G. Haffty, MD FACR FASTRO FASCO -
Q&A
ASBrS Benign Breast Disease Guidelines
Sun, May 4, 9:00 AM – 10:00 AM
Moderators: Helen A. Pass, MD, FACS; Katharine A. Yao, MD, FACS
-
Welcome and Introduction
Helen A. Pass, MD, FACS; Katharine A. Yao, MD, FACS -
Fibroadenoma and Fibroepithelial Lesions and Benign Phyllodes
Lorraine Tafra, MD, FACS -
Idiopathic Granulomatous Mastitis, Lactational Mastitis and Squamous Metaplasia of the Lactiferous Ducts
Katrina B. Mitchell, MD, IBCLC, FACS -
Atypia and Lobular Carcinoma in Situ
Tari A. King, MD, FACS, FSSO -
Other Benign Lesions
Amanda L. Amin, MD, MS, FACS -
Q&A
Key Updates From National and International Meetings
Sun, May 4, 10:00 AM – 11:00 AM
Moderators: Toan T. Nguyen, MD, FACS; Shayna L. Showalter, MD, FACS
-
Welcome and Introduction
Toan T. Nguyen, MD, FACS; Shayna L. Showalter, MD, FACS -
ASCO
Lisa A. Newman, MD, MPH, FACS, FASCO, FSSO -
San Antonio
Henry M. Kuerer, MD, PhD, FACS -
ASTRO
Bruce G. Haffty, MD FACR FASTRO FASCO -
St Gallen
Walter P. Weber, MD -
The Lancet Breast Cancer Commission
Stuart A. McIntosh, MBChB, PhD -
Q&A
Closing Ceremony: Vision of ASBrS for 2025-2026
Sun, May 4, 11:00 AM – 11:15 AM
Presenters: Michael P. Berry, MD, FACS; Judy C. Boughey, MD, FACS
